Conically expandable mitral valve repair device

The conically expandable mitral valve implant addresses the inefficiencies of conventional implants by using a fastener and L-shaped crowns for rapid, minimally invasive reconstruction, effectively reducing mitral regurgitation and surgical complications.

JP2024542660AActive Publication Date: 2024-11-15MERIL LIFE SCIENCES PVT LTD (100 00)
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
JP2024532318
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-17
Filing Date
2022-08-05
Publication Date
2024-11-15
Estimated Expiration
2042-08-05

AI Technical Summary

Technical Problem

Conventional mitral valve implants are time-consuming and risky, leading to increased surgical complications and are unsuitable for patients in poor health due to invasive open heart surgery.

Method used

A conically expandable implant with a fastener, crowns, and anchors is designed to reconstruct the mitral valve, featuring a L-shaped crown for even stress distribution and a rotating mechanism for rapid deployment, reducing the valve annulus diameter and minimizing tissue damage.

Benefits of technology

The implant efficiently reduces mitral valve regurgitation by quickly reconstructing the valve with minimal invasive procedures, reducing surgical time and complications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542660000001_ABST
    Figure 2024542660000001_ABST
Patent Text Reader

Abstract

An implant (100) for treating regurgitation in a mitral valve (100) is disclosed. The implant (100) comprises at least one fastener (50) including an apex portion (52) and a shank (54). The apex portion (52) includes a ring (51a) and a plurality of crowns (60). The crowns (60) include primary arms (61) and secondary arms (63), the primary arms (61) being longer than the secondary arms (63). The ring (51a) is attached to a proximal end (51) of the shank (54), and a nut (53a) is attached to a distal end (53) of the shank (54). The primary arms (61) are attached to the ring (51a), and the secondary arms (63) are attached to the nut (53a). The top portion (52) is rotated in a predetermined direction to cause upward movement of the nut (53a) to actuate the implant (100).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to medical devices, and more particularly, to medical devices for repairing the mitral valve. [Background technology]

[0002] The human heart has four valves: tricuspid, bicuspid (mitral), aortic, and pulmonary. The bicuspid valve is also known as the mitral valve. The mitral valve is located between the left atrium and the left ventricle and has two flaps. Mitral regurgitation is the most dangerous condition in which the leaflets of the mitral valve do not close properly, resulting in abnormal backflow of blood from the left ventricle to the left atrium. In mitral regurgitation, the left ventricle cannot utilize the blood according to its volume, resulting in the backflow of excess blood into the left atrium.

[0003] There are various causes of mitral regurgitation, such as valve prolapse, cord injury, rheumatic fever, endocarditis, myocardial abnormalities, and heart failure. Mitral regurgitation treatment depends on the severity of the condition. Generally, mild leaks are treated with drugs that specialize in improving the function of the heart. However, in severe leaks, surgery may be performed.

[0004] Traditionally, for cardiac surgery, open-heart surgery is performed. Such surgery typically involves cutting and opening the patient's chest (e.g., via a median sternotomy or thoracotomy approach). These procedures are painful and highly invasive, often resulting in medical complications, and can also result in delayed recovery times. Furthermore, patients who are not in good health may be unable to undergo open-heart surgery due to the risks associated with such surgery, and therefore may not receive necessary surgical treatment for their cardiac disease.

[0005] A transcatheter-based approach is utilized for the surgery, which may shorten the procedure time.

[0006] In such an approach, mitral valve regurgitation can be treated by repairing or reconstructing the leaflets of the native mitral valve. The mitral valve can be repaired by replacing the support chords and / or removing excess valve tissue, allowing the leaflets to close tightly together and thus reducing valve regurgitation. Mitral valve reconstruction (annuloplasty) can be performed by attaching a prosthetic annulus to the annulus. Alternatively, clips can be used to close the leaflets. Such devices may involve risky procedures that may take longer.

[0007] Alternatively, size-adjustable devices may be used to size and / or reconstruct the mitral valve. One such implant is disclosed in the application U.S. Pat. No. 6,399,433. However, the implant disclosed in said application may have several limitations, such as the need to consume more time to activate the implant at the implantation site, which may result in increased risks and complications associated with surgery. [Prior art documents] [Patent documents]

[0008] [Patent Document 1] U.S. Patent No. 9180005(B1) Summary of the Invention [Problem to be solved by the invention]

[0009] Therefore, there is a need for improved implants that can overcome the limitations of conventional implants. [Means for solving the problem]

[0010] The present invention relates to an implant for treating regurgitation in the mitral valve. The implant comprises at least one fastener including an apex portion and a shank. The apex portion includes a ring and a plurality of crowns. The crown includes primary and secondary arms, the primary arms being longer than the secondary arms. The ring is attached to a proximal end of the shank and a nut is attached to a distal end of the shank. The apex portion is rotated in a predetermined direction to cause upward movement of the nut to actuate the implant.

[0011] The foregoing and other features and advantages of the present invention will become more apparent from the following detailed description which proceeds with reference to the accompanying drawings.

[0012] The above summary and the following detailed description of exemplary embodiments will be better understood when read in conjunction with the accompanying drawings. For the purpose of illustrating the disclosure, exemplary structures of the disclosure are shown in the drawings. However, the disclosure is not limited to the specific methods and instrumentalities disclosed herein. Moreover, those skilled in the art will appreciate that the drawings are not to scale. [Brief description of the drawings]

[0013] [Figure 1] FIG. 1 illustrates an implant 100 according to one embodiment of the present invention. [Figure 1a] 1 illustrates an implant 100 fastener 50 according to one embodiment of the present invention. [Figure 1b] FIG. 2 illustrates a crown 60 of an implant 100 according to one embodiment of the present invention. [Diagram 2] 1 is a flow diagram of the process involved in manufacturing an implant 100 according to one embodiment of the present invention. [Diagram 3] FIG. 3 illustrates a delivery device 300 according to one embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0014] Before describing the invention in detail, certain words and phrases used throughout this patent document are defined. The words "including" and "comprises" and their derivatives mean open-ended inclusion. The word "or" is non-exclusive and means "and / or." The words "coupled to" and "related to" and their derivatives can mean including, contained within, interconnected with, containing, contained within, connected to, coupled to, in communication with, cooperating with, interleaved, juxtaposed, located near, bounded by, bounded by, or having the nature of, etc. The definitions of certain words and phrases are applied throughout this patent document, and those skilled in the art will understand that such definitions will apply in many, if not most, instances to past and future uses of the words and phrases so defined.

[0015] Throughout this specification, the term "one embodiment" or similar phrases means that a particular feature, structure, or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, throughout this specification, the term "one embodiment" or similar phrases may, but do not necessarily, refer to the same embodiment, and mean "one or more, but not all, embodiments" unless expressly stated otherwise. The words "including," "comprising," "having," and variations thereof mean "including, but not limited to," unless expressly stated otherwise. Listed items do not imply that any or all of the items are mutually exclusive and / or mutually non-exclusive, unless expressly stated otherwise. Additionally, the words "a," "an," and "the" refer to "one or more," unless expressly stated otherwise.

[0016] Although the implementation of the exemplary embodiments of the method of the present disclosure may be described in a certain sequential order for convenience of presentation, it should be understood that the embodiments of the present disclosure may include implementation orders that differ from the specific sequential order disclosed. For example, implementations described sequentially may be altered or performed simultaneously in some examples. Furthermore, the description and disclosure presented in relation to a particular embodiment is not limited to that embodiment, but may apply to any embodiment disclosed herein. Moreover, for the sake of simplicity, the accompanying drawings may not illustrate the various ways in which the systems, methods, and devices of the present disclosure may be used in combination with other systems, methods, and devices.

[0017] Moreover, the described characteristics, advantages, and features of the embodiments may be combined in any suitable manner. Those skilled in the relevant art will understand that the embodiments may be practiced without one or more of the specific features or advantages of a particular embodiment. In other instances, additional features and advantages may be recognized in some embodiments and may not be present in all embodiments. These features and advantages of the embodiments will become more fully apparent from the following description and appended claims, or may be learned by practice of the embodiments set forth hereinafter.

[0018] In accordance with the present disclosure, a medical implant (implant) is disclosed. The implant is used to treat mitral regurgitation in a patient. However, it is noted that application of the implant of the present invention may be extended to treat tricuspid regurgitation in a patient.

[0019] The implant may include at least one fastener, a slotted nut, a plurality of crowns and anchors coupled together in a predetermined manner that allows for conical expansion of the implant. The crown may be configured with an L-shaped structure that promotes equal stress distribution in both arms during actuation, thereby preventing damage to the tissue wall.

[0020] The implant may be a conically expandable implant, which may be used to treat mitral annular regurgitation when the native annulus size is between 28 mm and 40 mm.

[0021] Referring now specifically to the drawings, Figure 1 shows an implant 100. The implant 100 may be deployed at the mitral valve annulus to remodel and / or reconnect the mitral valve leaflets, thereby reducing the mitral valve annulus diameter and reducing regurgitation.

[0022] The implant 100 is shown in a conically expandable configuration. The implant 100 may include one or more components coupled together in a predetermined manner. The implant 100 may be used in mitral valves where the native annulus diameter is greater than 25 mm.

[0023] Implant 100 may include, but is not limited to, at least one fastener 50, a plurality of crowns 60, and a plurality of anchors 70. These components of implant 100 are designed to work together as a functional unit to repair mitral valve stenosis in a patient.

[0024] The fastener 50 may be made from, but is not limited to, 316L SS, 316LVM SS, 304 SS, Nitinol, hi one embodiment, the fastener 50 is made from 316L SS.

[0025] Fastener 50 (as shown in FIG. 1a) may include a top portion 52 and a shank 54. Shank 54 includes a proximal end 51, a distal end 53, and a length L1 extending between proximal end 51 and distal end 53. Length L1 may be in the range of 10 mm to 30 mm. In one embodiment, length L1 is 20 mm. Top portion 52 of fastener 50 includes a ring 51a attached to shank 54 as described in the following paragraphs.

[0026] The shank 54 may include a predetermined outer diameter in the range of 1 mm to 5 mm. In one embodiment, the outer diameter is 3 mm. The shank 54 may have a screw thread. The shank 54 may include a predetermined pitch in the range of 0.3 mm to 0.8 mm. In one embodiment, the thread pitch of the shank 54 is 0.5 mm.

[0027] The fastener 50 may include at least one slot (not shown) disposed at each of the proximal and distal ends 51, 53. The slot at the proximal end 51 of the shank 54 may be used to receive the ring 51a of the top portion 52, and the slot at the distal end 53 of the shank 54 may be used to receive the nut 53a as shown in FIG. 1. The top portion 52 of the implant 100 may be rotated in a predetermined direction to actuate the implant 100 at the implantation site. In one embodiment, the top portion 52 is rotated in a clockwise direction. Rotation of the top portion 52 induces upward movement of the nut 53a, resulting in radial contraction of the crown 60 and actuation of the implant 100.

[0028] The ring 51a may be fixedly mounted on the shank 54 by welding. The nut 53a may be removably threaded onto the shank 54. The ring 51a and the nut 53a may each include a plurality of first grooves 51b and a plurality of second grooves 53b. The plurality of grooves 51b and 53b may be used to mount the crown 60 as described below. The plurality of grooves 51b and 53b may be in the range of 5 to 10. In one embodiment, the ring 51a and the nut 53a include six grooves 51b and 53b. Each of the grooves 51b and 53b is located equidistant from each other. The grooves 51b and 53b may have various shapes, such as, but not limited to, rectangular, circular, square, and the like. In one embodiment, the grooves 51b and 53b are rectangular in shape.

[0029] The ring 51a may have a diameter in the range of 4 mm to 8 mm. In one embodiment, the diameter of the ring 51a is 6 mm. The nut 53a may have a diameter in the range of 2 mm to 8 mm. The pitch of the nut 53a may be in the range of 0.3 mm to 0.8 mm. In one embodiment, the pitch of the nut 53a is 0.5 mm.

[0030] The crown 60 may be manufactured in a predetermined shape, including but not limited to an L-shape, a W-shape, and the like. In one embodiment, the crown 60 is manufactured in an L-shape as shown in FIG. 1b. The L-shape design of the crown 60 reduces stress on the implant 100, thus preventing damage to the native annulus of the mitral valve and aiding in the smooth operation of the mitral valve. Furthermore, the L-shape of the crown 60 may facilitate assembling the device in a simple manner.

[0031] The implant 100 may include a predetermined number of crowns 60. The predetermined number of crowns 60 may be in the range of 6 to 10. In one embodiment, the implant 100 includes seven crowns 60. The crowns 60 may include at least two arms, namely, a primary arm 61 and a secondary arm 63. The crowns 60 may be used to assemble the anchors 70, the fasteners 50, and the nuts 53a. Additionally, the crowns 60 may be used to perform expansion and contraction of the implant 100 at the implantation site. The primary arms 61 may be longer than the secondary arms 63 in a predetermined ratio. In one embodiment, the primary arms 61 are twice as long as the secondary arms 63. The primary arms 61 may include a proximal end 61a, a distal end 61b, and a length L2 extending between the primary arms 61 and the secondary arms 63. The length L2 may be in the range of 25 mm to 32 mm. In one embodiment, the length L2 is 28 mm.

[0032] The secondary arm 63 may branch off from the distal end 61b of the primary arm 61 at a predetermined length L3. The length L3 may be in the range of 4 mm to 8 mm. In one embodiment, the length L3 is 6 mm. The secondary arm 63 may include a proximal end 63a, a distal end 63b, and a length L4 extending between the proximal end 63a and the distal end 63b. The length L4 may be in the range of 10 mm to 15 mm. In one embodiment, the length L4 is 12 mm.

[0033] In yet another embodiment, the secondary arm 63 is longer than the primary arm 61 .

[0034] The primary arm 61 and the secondary arm 63 may be straight or curved. In one embodiment, the primary arm 61 and the secondary arm 63 are slightly curved with a radius of curvature ranging from 18 mm to 25 mm. In one embodiment, the radius of curvature is 21 mm. The two arms of the crown 60 may have a predetermined thickness ranging from 300 microns to 750 microns. In one embodiment, the thickness is 550 microns.

[0035] Crown 60 may be assembled with fastener 50 by grooves 51b and 53b in ring 51a and nut 53a, respectively. Crown 60 may be secured by, but is not limited to, welding, adhesive, snap fastening mechanisms, and the like. In one embodiment, crown 60 is secured by welding. Primary arm 61 may be attached to ring 51a and secondary arm 63 may be attached to nut 53a, as described below.

[0036] The primary arm 61 may include a first connecting structure 62 at the proximal end 61a. The first connecting structure 62 may be configured in a shape such as, but not limited to, a beak-shaped structure, a T-shaped structure, and the like. In one embodiment, the first connecting structure 62 is configured in a beak-shaped structure. The first connecting structure 62 may be mounted within a plurality of first grooves 51b of the ring 51a of the fastener 50. Additionally, the secondary arm 63 may be mounted within a plurality of second grooves 53b of the nut 53a. Additionally, the primary arm 61 may include a second connecting member 64 at the distal end 61b as shown in FIG. 1. The second connecting member 64 may be used to assemble the anchor 70 to the crown 60. The second connecting member 64 may be manufactured in a predetermined shape such as, but not limited to, a rectangular shape, a square shape, an oval shape, and the like. In one embodiment, the second connecting member 64 is rectangular in shape. The second connecting member 64 may include a number of slots (not shown) for mounting the anchors 70 on the crown 60 as shown in Figure 3. These number of slots may be used to provide a smooth transition to the anchors 70 upon actuation of the implant 100.

[0037] The crown 60 may be made of a biocompatible metallic material such as, but not limited to, SS (stainless steel) alloy, Nitinol alloy (TiNi-SS, TN3, TNG, TiNi-YY, Ti-Ni-01, and Ti-Ni-02), and CoCr (cobalt chromium) alloy. In one embodiment, the crown 60 of the implant 100 is made of Nitinol alloy because Nitinol alloy has superelastic and shape memory properties.

[0038] The anchors 70 may be elastic members, such as springs, coils, etc. In one embodiment, the anchors 70 are coils. The implant 100 may include a number of anchors 70 ranging from 6 to 10. In one embodiment, the implant 100 includes 9 anchors. The anchors 70 may aid in anchoring the implant 100 onto the annulus of the mitral valve. The anchors 70 may be manufactured by winding a wire with a diameter ranging between 0.1 mm and 0.4 mm. In one embodiment, the diameter is 0.2 mm. The anchors 70 may have a pitch ranging from 0.5 mm to 3 mm. In one embodiment, the pitch of the anchors 70 is 1 mm.

[0039] Anchor 70 may have a proximal end 71, a distal end 73, and a length L5 extending between proximal end 71 and distal end 73. Length L5 may range from 5 mm to 20 mm. In one embodiment, length L5 is 12 mm. Length L5 may vary according to the thickness of the native annulus of the mitral valve.

[0040] Anchor 70 may be attached to crown 60. In one embodiment, distal end 61b of primary arm 61 is attached to proximal end 71 of anchor 70. Anchor 70 may be manually attached to crown 60. Additionally, distal end 73 of anchor 70 may have a sharpened edge that may facilitate effective penetration of implant 100 into the tissue wall of the native mitral valve with minimal trauma to the tissue to facilitate anchoring of implant 100. Alternatively, distal end 73 includes a hook (not shown) that may facilitate penetration of anchor 70 into the tissue wall.

[0041] The anchor 70 may be made from a metallic material such as, but not limited to, 316L SS, 316LVM SS, 304 SS, etc. In one embodiment, the anchor 70 is made from 316L SS.

[0042] FIG. 2 shows a flow diagram of the process involved in manufacturing the implant 100 according to the present invention. The process begins at step 201. In step 201, a tube made of Nitinol is subjected to a cutting process to form the crown 60. The Nitinol tube may be an oxide-free tube. The cutting may be performed by any means, such as, but not limited to, liquid jet machining, laser cutting, abrasive jet machining, etc. In one embodiment, the cutting of the Nitinol tube is performed by laser cutting. The tube may have an outer diameter in the range of 4 mm to 6 mm. In one embodiment, the outer diameter of the tube is 5.5 mm. Additionally, the tube may have a predetermined wall thickness in the range of 0.40 mm to 0.90 mm. In one embodiment, the thickness of the tube is 0.6 mm.

[0043] Laser cutting may be performed using gases such as, but not limited to, argon gas or oxygen gas. In one embodiment, laser cutting is performed using argon gas. The pressure of the argon gas may be maintained within the range of 2 bar to 18 bar.

[0044] In step 203, the crown 60 obtained in the previous step undergoes a polishing and honing process to create a smooth surface. The polishing process can be performed by diamond files and / or abrasive files. In one embodiment, the honing is performed using a 3.4mm to 3.5mm polishing wheel. Alternatively, an abrasive gel may be further used to remove burrs generated during the laser cutting process.

[0045] In step 205, the crown 60 undergoes a shape fixing process after the polishing and honing in the previous steps. This shape fixing process may be performed by heat treatment using a mold. The shape fixing is performed in several steps. First, the laser cut crown 60 is expanded by using a mandrel from a crimped diameter in the range of 3 mm to 5 mm to an expanded diameter in the range of 20 mm to 45 mm. After expansion, the crown 60 may undergo a molding process to give a predetermined radius of curvature to the crown 60. The molding process is performed in three steps. The molding process may be performed at a temperature of 505° C. for 10 minutes to 15 minutes. In one embodiment, the molding is performed at 505° C. for a period of 15 minutes.

[0046] In step 207, the crown 60 is subjected to a sandblasting process. The sandblasting process may be performed using aluminum oxide powder. The aluminum oxide powder may strike the crown 60 at a predetermined frequency for a predetermined period of time. The predetermined frequency and the predetermined period may be in the range of 45-85 Hz and 3-10 minutes, respectively. In one embodiment, the frequency is in the range of 55-65 Hz and the time is 5-8 minutes. The pressure applied by the powder may vary in the range of 20 psi to 90 psi, preferably in the range of 30 psi to 60 psi. The sandblasting process may create a very smooth outer surface on the crown 60 by ablation with the aluminum powder. The sandblasting process may also remove the oxide layer and striations left by the laser cutting in the previous step, reduce the tendency to microcrack, and / or provide a light texture to the outer surface of the crown 60.

[0047] Finally, in step 209, the crown 60 undergoes an electropolishing process. The electropolishing process is performed by immersing the implant 100 in an electrolyte solution and passing a current at a predetermined voltage for a predetermined period of time. The electrolyte solution may be a concentrated acid solution, such as a mixture of 20%-25% purfluoric acid and 75%-80% acetic acid. The voltage used for electropolishing is 8V-12V and the current is 0.3A-1.5A, preferably 0.8A-0.10A. The predetermined period of time is in the range of 1 minute-8 minutes, preferably 2-6 minutes.

[0048] In step 211, components such as fastener 50, crowns 60, and anchors 70 are assembled together to form implant 100 as shown in FIG.

[0049] In step 213, the implant 100 is loaded onto a delivery device 300 as shown in FIG.

[0050] The delivery device 300 may include a shaft 310 and a body 320. The shaft 310 may include a proximal end 311 and a distal end 313. The shaft 310 may include a head 315 at the proximal end 311.

[0051] The body 320 may include one or more rollers, such as a proximal roller 321, a distal roller 322, and a set of at least one guide plate 323. The proximal roller 321 and the distal roller 322 of the delivery device 300 are attached to the anchor 70 and the fastener 50 of the implant 100, respectively. The proximal roller 321 may include two shafts, such as a plain shaft 324 and a threaded shaft 325. The threaded shaft 325 may allow rotational movement in a clockwise and counterclockwise direction. The plain shaft 324 of the proximal roller 321 allows axial movement forward and backward.

[0052] The proximal roller 321 is coupled to the anchor 70 with the aid of a wire 327 located in the hook of the anchor 70 to secure the implant 100 on the tissue annulus. The distal roller 322 is coupled to the top portion 52 with the aid of a wire 327 to rotate the fastener 50 and actuate the implant 100. The guide plate 323 is disposed between the proximal roller 321, the distal roller 322 and the implant 100 and is primarily used to guide the wire 327 relative to these components and allow their individual movement relative to the implant 100.

[0053] At step 215, the implant 100 undergoes a primary packaging process. The implant 100 may be packaged in a pouch made from aluminum along with the delivery device 300. Similarly, the implant 100 may be packaged in a pouch made from aluminum along with the delivery device 300.

[0054] After primary packaging, the implant 100 undergoes a primary sterilization process at step 217. This primary sterilization process may be performed by gas sterilization using a gas such as ETO (ethylene oxide) gas, nitrogen gas, etc. In one embodiment, the primary sterilization process is performed with ETO (ethylene oxide) gas.

[0055] At step 219, the implant 100 undergoes a secondary packaging process. During the secondary packaging process, the implant 100 may be packaged in a plastic box, a cardboard box, etc. In one embodiment, the implant 100 is packaged in a plastic box.

[0056] After secondary packaging, the implant 100 may be stored at a predetermined temperature, step 221. In one embodiment, the implant 100 is stored at room temperature.

[0057] The invention will now be illustrated with the aid of the following examples.

[0058] The invention will now be illustrated with the aid of the following examples. EXAMPLES

[0059] Example 1 (Invention): An in-vitro tissue model of the mitral valve was used, with the leaflets having an initial diameter of 36 mm. An implant with a diameter of 40 mm in a conically expandable configuration was prepared. The implant was placed over the leaflets of the mitral valve and anchored with the aid of anchors. Once the anchors were positioned and fixed on the leaflets of the in-vitro tissue model, the implant was actuated by rotating a single fastener. When the fastener was rotated with the aid of a spanner, the nut moved upwards, resulting in a crimping of the implant and a reduction in the leaflet diameter from 36 mm to 30 mm. The time required to perform this entire process in an effective manner was 20 minutes in the in-vitro model. EXAMPLES

[0060] Example 2: An in-vitro tissue model of mitral valve was used, which includes a valve leaflet with an initial diameter size of 34 mm. An implant with a diameter of 38 mm and a V-shaped crown and a fastener was used at the treatment site. It was found that the V-shaped crown of the implant was subjected to higher stress at the treatment site. Moreover, the time required for valve repair was relatively longer than that of the present invention.

[0061] The scope of the present invention is limited only by the appended claims. More generally, all parameters, dimensions, materials, and configurations described herein are intended to be exemplary, and those of ordinary skill in the art will readily appreciate that the actual parameters, dimensions, materials, and / or configurations will depend on the particular application or applications utilizing the teachings of the present invention. [Explanation of symbols]

[0062] 50 Fastener 51 Proximal end 51a Ring 51b First Groove 52 Top part 53 Distal end 53a Nut 53b Second Groove 54 Shank 60 crowns 61 Primary Arm 61a Proximal end 61b Distal end 62 First connecting structure 63 Secondary Arm 63a Proximal end 63b Distal end 64 Second connecting member 70 Anchor 71 Proximal end 73 Distal end 100 Implants 300 Delivery Device 310 Shaft 311 Proximal end 313 Distal end 315 Head 320 Main Unit 321 Proximal Roller 322 Distal Roller 323 Guide Plate 324 Plain Shaft 325 threaded shaft 327 Wire L1 Length L2 Length L3 Length L4 Length L5 Length

Claims

1. 1. An implant (100) for treating regurgitation in a mitral valve, comprising: a. at least one fastener (50) including a top portion (52) and a shank (54), said top portion (52) including a ring (51a); b. a plurality of crowns (60) including primary arms (61) and secondary arms (63), said primary arms (61) being longer than said secondary arms (63); Equipped with The ring (51a) of the top portion (52) is attached to the proximal end (51) of the shank (54) and a nut (53a) is attached to the distal end (53) of the shank (54); The primary arm (61) is attached to the ring (51a) and the secondary arm (63) is attached to the nut (53a); An implant (100) for treating regurgitation in the mitral valve, wherein the top portion (52) is rotated in a predetermined direction to cause upward movement of the nut (53a), resulting in radial contraction of the crown (60) to effect operation of the implant (100) at the implantation site.

2. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the ring (51a) is fixedly attached to the shank (54).

3. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the nut (53a) is removably attached to the shank (54).

4. The implant (100) for treating regurgitation in a mitral valve according to claim 1, wherein the plurality of crowns (60) comprises between six and ten crowns.

5. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the primary arm (61) is twice as long as the secondary arm (63).

6. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the primary arm (61) and the secondary arm (63) are slightly curved.

7. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the ring (51a) and the nut (53a) include a plurality of grooves (51b) and (53b).

8. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein the primary arm (61) includes a first connecting structure (62) at a proximal end (61a).

9. 2. The implant (100) for treating regurgitation in a mitral valve as recited in claim 1, wherein a plurality of anchors (70) are provided for securing the implant (100) at the implantation site.

10. The implant (100) for treating regurgitation in a mitral valve according to claim 9, wherein the plurality of anchors (70) comprises between six and ten anchors.

Citation Information

Patent Citations

  • Prosthesis delivery system with positioning function

    CN110179566A

  • Prosthesis system with positioning mechanism

    CN112932743A

  • Implantable devices for controlling the size and shape of anatomical structures or lumens

    JP2009537278A

  • Devices and methods for treating vascular insufficiency

    JP2019520167A

  • Device for in situ delivery of a heart valve prosthesis - Patent Application 20070122997

    JP2021526434A